Navigation Links
Reovirus in Medical News
Scientists Develop a Harmless Multi-Tasking Reovirus
For the past two years, researchers at Oncolytics Biotech have been developing a harmless virus as a potent cancer killer//, but they have also been accumulating data that suggests in addition to directly killing tumor cells, the reovirus may prime the immune system to mount a separate, powerful an...Harmless Virus May Be Deadly to Breast Cancer
... reovirus seeks out and destroys tumor cells, researchers sa...Canadian researchers report. "We suspected that reovirus might be effective against cancer stem cells, beca...id. Lee noted that he and his colleagues tested reovirus on fresh breast cancer tissue removed from a patie...Cedars-Sinai Medical Center opens patient trial of virus that attacks brain cancer cells
...inated by the body within two weeks. But while the reovirus (respiratory enteric orphan virus) may be harmless...Ras pathway) that controls key cell functions. The reovirus is able to infect and kill cancer cells that have ..., developed a therapeutic drug, REOLYSIN, from the reovirus and are conducting multicenter clinical trials for...Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs
...chemotherapy drugs. In general, the combination of reovirus with cisplatin, gemcitabine, mitomycin or vinblast...ar interest to the researchers, the combination of reovirus and paclitaxel, a common chemotherapy drug, was un...reovirus. The data suggest that the combination of reovirus and paclitaxel may help in promoting cell-death si...Cancer-Killing Viruses Employ Multiple Mechanisms
... recently however, it has been discovered that the reovirus may also have the potential to prime the body’s ow... “We’ve understood the mechanism of action of reovirus replication in cancer for a number of years,” expl...irus was gone.” Immunologic work now suggests that reovirus exposure is “educating” the immune system to recog......n a set of experiments involving cancer cell lines grown in the laboratory, reovirus destroyed cancer cells in 20 out of the 24 cell lines. It was also found th...Ninety days after being treated, the majority of the mice treated with live reovirus were still alive, but all of the animals injected with the dead virus had d...
Reovirus in Medical Technology
CALGARY, July 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) ('Oncolytics') reported today that Dr. Shizuko Sei et al. published the results of their work examining reovirus and chemotherapy against human non-small cell lung cancer (NSCLC). The paper, entitled "Syn...
...re now being sponsored by our collaborators." The primary objectives of the trial are to assess the presence, replication and anti-cancer effects of reovirus within liver metastases after intravenous administration of REOLYSIN(R) by examination of the resected tumour. Secondary objectives include assessing ...
...y that an abstract covering preclinical work using reovirus in combination with gemcitabine is available today...tated Human HCT116 Xenografts." The combination of reovirus and gemcitabine was more effective than gemcitabine or reovirus alone at killing human colon cancer cells in a mou...
...ncolytics Biotech Inc. ("Oncolytics") announces that a poster by Dr. Maureen E. Lane et al. of , New York, entitled "In Vivo Synergy between Oncolytic reovirus and Gemcitabine in Ras-Mutated Human HCT116 Xenografts" is scheduled to be presented today at the American Association for Cancer Research (AACR) Annu...
...nal results of Oncolytics' U.K. Phase I systemic administration trial. The poster, entitled "Final Results of a Phase I Study of Wild-Type Oncolytic reovirus Administered Intravenously to Patients with Advanced Cancer" is scheduled to be presented by Dr. James Spicer of The Royal Marsden Hospital and The In...
...re now being sponsored by our collaborators." The primary objectives of the trial are to assess the presence, replication and anti-cancer effects of reovirus within liver metastases after intravenous administration of REOLYSIN(R) by examination of the resected tumour. Secondary objectives include assessing ...
...y that an abstract covering preclinical work using reovirus in combination with gemcitabine is available today...tated Human HCT116 Xenografts." The combination of reovirus and gemcitabine was more effective than gemcitabine or reovirus alone at killing human colon cancer cells in a mou...
...ncolytics Biotech Inc. ("Oncolytics") announces that a poster by Dr. Maureen E. Lane et al. of , New York, entitled "In Vivo Synergy between Oncolytic reovirus and Gemcitabine in Ras-Mutated Human HCT116 Xenografts" is scheduled to be presented today at the American Association for Cancer Research (AACR) Annu...
...nal results of Oncolytics' U.K. Phase I systemic administration trial. The poster, entitled "Final Results of a Phase I Study of Wild-Type Oncolytic reovirus Administered Intravenously to Patients with Advanced Cancer" is scheduled to be presented by Dr. James Spicer of The Royal Marsden Hospital and The In...
Reovirus in Biological News
Oncolytics Biotech, Inc. announces publication of research
...mor efficacy and safety of various combinations of reovirus and cyclophosphamide in vivo. The paper, entitled...cutaneous Tumors following Intravenous Delivery of reovirus appears online in the January 1, 2008 issue of Cli...or, to enhance the delivery and replication of the reovirus when delivered intravenously. After testing vario...Dealing deadly cancers a knockout punch
... in human clinical trials. Oncolytics' proprietary reovirus formulation, Reolysin®, is active against numerous...ttsdale, Arizona, several presentations focused on reovirus efficacy alone or in combination with standard che...nvestigators examined the tumor-killing ability of reovirus plus cisplatin, a standard chemotherapy agent, in ...Reovirus in Biological Technology
CALGARY, July 15 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) announced today that a poster presentation by Dr. Jacqueline Parker et al. entitled "Anti-Tumor Activity of Reovirus is Synergistically Enhanced in Combination with Temozolomide and Low Dose Irradiation i...
CALGARY, March 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) announced results of two preclinical studies that were presented at the Fifth International Meeting on Replicating Oncolytic Virus Therapeutics. The meeting was held in Banff, Alberta from March 18th to ...
CALGARY, Oct. 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that Dr. Shizuko Sei of SAIC-Frederick, Inc., delivered a poster presentation entitled "In Vivo Efficacy and Replication Dynamics of Intravenously Administered Oncolytic Reovirus in Nude ...
CALGARY, April 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that Prof. Alan Melcher and his research group at St. James's University Hospital in Leeds, U.K. published the results of their work with reovirus in the May 1, 2008 online ...
CALGARY, April 15 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced that an oral presentation by Dr. Chandini Thirukkumaran of the Tom Baker Cancer Centre, Calgary, entitled "Targeting Multiple Myeloma with Oncolytic Viral Therapy" was presented today at the A...
CALGARY, April 15 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced that a poster presentation by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled "Radiation in Combination with Reolysin for Pediatric Sarcomas" was presented today a...
CALGARY, March 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) announced results of two preclinical studies that were presented at the Fifth International Meeting on Replicating Oncolytic Virus Therapeutics. The meeting was held in Banff, Alberta from March 18th to ...
Oncolytics Biotech(R) Inc. Announces Reovirus Research to be Presented at AACR Annual Meeting
CALGARY, March 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) announced today that abstracts covering research with reovirus (REOLYSIN(R)) are available on the American Association for Cancer Research (AACR) website at www.aacr.org , and on the Oncolytics website ...CALGARY, Oct. 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that Dr. Shizuko Sei of SAIC-Frederick, Inc., delivered a poster presentation entitled "In Vivo Efficacy and Replication Dynamics of Intravenously Administered Oncolytic Reovirus in Nude ...
Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at ASGT Meeting
CALGARY, May 30 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that two presentations covering preclinical work using the reovirus are scheduled to be delivered by Dr. Richard Vile of the Mayo College of Medicine, Rochester, Minnesota, at the American...CALGARY, April 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that Prof. Alan Melcher and his research group at St. James's University Hospital in Leeds, U.K. published the results of their work with reovirus in the May 1, 2008 online ...
Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma
CALGARY, April 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that Prof. Alan Melcher and his research group at St. James's University Hospital in Leeds, U.K. published the results of their work in the April 10 online issue of Gene The...CALGARY, April 15 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced that an oral presentation by Dr. Chandini Thirukkumaran of the Tom Baker Cancer Centre, Calgary, entitled "Targeting Multiple Myeloma with Oncolytic Viral Therapy" was presented today at the A...
CALGARY, April 15 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced that a poster presentation by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled "Radiation in Combination with Reolysin for Pediatric Sarcomas" was presented today a...
Oncolytics Biotech Inc. Collaborators to Present Reovirus Research at AACR Annual Meeting
CALGARY, March 13 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced that two abstracts covering preclinical work with reovirus are available today on the American Association for Cancer Research (AACR) website at http://www.aacr.org, and on the Oncolytics we...Other TagsOther Contents
SurveScriptInterlinkCarbonylHalvesGerekeenCelebratedUttaranchalHillyRecountsSurvivordisseminatedSipa
(Date:5/24/2013)... 24, 2013 Today, Zane Benefits, ... Indiana Health Insurance Exchange . Zane Benefits, which ... sponsored health benefits, is the leader in ... arrangements . , According to Zane Benefits’ website, ... Care Act (ACA), health insurance coverage for individuals ...
(Date:5/24/2013)... 24, 2013 This week is National ... their efforts to provide the best emergency care and ... this week is also to educate the public that ... survival. Citizens are the first link, and a very ... bystander CPR after a cardiac arrest can triple a ...
(Date:5/24/2013)... Mozes HealthDay Reporter , , FRIDAY, May 24 ... accomplishments are remarkable. But it was a physical challenge ... top of her sport. "I was an 11-year-old ... my scoliosis was diagnosed by my orthopedic surgeon," said ... Scoliosis Research Society and the American Academy of Orthopaedic ...
(Date:5/24/2013)... May 24, 2013 Western University of ... status of “Full Accreditation” for the next seven years ... Education (COE). , “This is a magnificent achievement, and ... work and student outcomes,” said College of Veterinary Medicine ... my appreciation to the faculty, staff, preceptors, and students ...
(Date:5/24/2013)... KC and Monica Craichy, Founders of Living Fuel, Inc ... Kyle and Austin Craichy, will be kiteboarding with members of ... , KC Craichy said he is excited to be involved ... that virtually everyone who planned to be involved is going ... meet at Matheson Hammock Park and Beach in Miami at ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 3Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 4Health News:Acadian Medics Reunite with Miracle Baby 2Health News:Top-Ranked Golfer Beats Scoliosis 2Health News:Top-Ranked Golfer Beats Scoliosis 3Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 2Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 3[0] Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange[0] Acadian Medics Reunite with Miracle Baby[0] Top-Ranked Golfer Beats Scoliosis[0] College of Veterinary Medicine Earns Seven-year Accreditation[0] FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa
(Date:5/23/2013)... the world,s most popular fruit, can be made both ... GM varieties. , "Working with GM tomatoes that ... of a specific compound, allows us to pinpoint exactly ... Martin from the John Innes Centre. , The research ... health and shelf life characteristics because even higher levels ...
(Date:5/23/2013)... than 13,000 ships per year, carrying more than 284 million ... roughly $1.8 billion dollars in toll fees for the Panama ... 55 million gallons of water are used from Gatun Lake, ... million people living in the isthmus. , However, the ... 20 percent of the ships at sea, has demanded change. ...
(Date:5/23/2013)... By discovering the new mechanism by which estrogen suppresses ... revealed a potential new approach toward treating certain liver ... and colleagues believe they are changing long-held views in ... issue of the journal Science Signaling . , ... years has been that only receptors located in the ...
Breaking Biology News(10 mins):The world's favorite fruit only better-tasting and longer-lasting 2Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |